サイクロヘクセニル核酸化物を含む小干渉RNAの構造的特徴と生物学的評価
Koen Nauwelaerts1, Michael Fisher, Matheus Froeyen
1Laboratory of Medicinal Chemistry, Rega Institute for Medical Research, Minderbroedersstraat 10, Leuven, Belgium.
Journal of the American Chemical Society
|July 10, 2007
まとめ
サイクロヘクセニル核酸 (CeNA) オリゴヌクレオチドは,siRNAの代替品として有望を示しています. CeNA:RNAデュプレックスはPIWIタンパク質の相互作用を維持し,遺伝子の静止活性を強化し,治療用途の可能性を示唆しています.
科学分野:
- オリゴヌクレオチドの化学反応
- 構造生物学 構造生物学とは
- 分子生物学は分子生物学である.
背景:
- サイクロヘクセニル核酸 (CeNA) は,リボース糖がサイクロヘクセニル部分に置き換えられた改変されたオリゴヌクレオチドです.
- CeNAの構造的および機能的特性を理解することは,その潜在的な治療的応用にとって極めて重要です.
研究 の 目的:
- CeNA:RNA複合体のNMR構造を決定する.
- PIWIタンパク質内のCeNA:RNAデュプレックスをモデル化するために.
- 小型の干渉RNA (siRNA) 療法におけるCeNAの成分としての可能性を評価する.
主な方法:
- 核磁共振 (NMR) スペクトロスコーピーは,二重構造を決定する.
- PIWIタンパク質とのCeNA:RNAデュプレックス相互作用を視覚化するための分子モデリング.
- CeNAを含むsiRNAsの遺伝子静止効果を評価するためのインビトロアッセイ.
主要な成果:
- CeNA:RNAデュプレックスは,はっきりとしたパックリングとトルションの角度を持つA型の螺旋形状を採用しました.
- モデリングは,PIWIタンパク質へのCeNA結合が二重鎖RNA (dsRNA) に似ていることを明らかにしました.
- CeNA単位をsiRNAに組み込むと,同様のまたは強化された遺伝子の静止活性が生じました.
結論:
- CeNA改変オリゴヌクレオチドは,構造的整合性とRNA干渉に必要なタンパク質相互作用を維持する.
- CeNAベースのsiRNAは,改変されていないsiRNAと比べたり,より優れている強力な遺伝子サイレンシングを示しています.
- CeNAは,次世代のsiRNA療法を開発するための有望な代替案です.
関連する概念動画
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
02:47Ribozymes
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes can be...